GoodRx enters Sixth Amendment to Credit Agreement, refinances $500M term loan facility

GoodRx Holdings, Inc.

New $500M 2024 Term Loan Facility matures July 2029 with SOFR + 3.75% margin, used to repay Existing Term Loans ($167.2M cash added).
Maturity of $88M of $100M revolving credit facility extended to April 2029; remaining $12M terminates July 2025.
Quarterly principal payments of 0.25% of original principal beginning Q2 2024, prepayment premium 1.00% if before Jan 2025.
Financial covenant requires First Lien Net Leverage Ratio not exceeding 8.2x if revolving borrowings exceed threshold.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.